302
Participants
Start Date
March 30, 2012
Primary Completion Date
November 28, 2014
Study Completion Date
August 7, 2020
Everolimus
Participants were treated with everolimus 10 mg (two 5 mg tablets) once daily orally taken
Placebo
Participants were treated with two tablets of matching placebo once daily orally taken.
Best suportive care (BSC)
Best supportive care includes all care provided to participants deemed necessary by the treating physician, such as but not restricted to anti-diarrheals and analgesics. The optimal care of the patient is based on the treating physician's best medical judgment.
Novartis Investigative Site, Kaohsiung City
Novartis Investigative Site, Budapest
Novartis Investigative Site, Budapest
Novartis Investigative Site, Brussels
Novartis Investigative Site, Parktown
Novartis Investigative Site, Edegem
Novartis Investigative Site, Leuven
Novartis Investigative Site, Innsbruck
Novartis Investigative Site, Ghent
Memorial Sloan Kettering MSkCC SC, New York
Novartis Investigative Site, Taipei
Novartis Investigative Site, Bangkok
Montefiore Medical Center MMC, The Bronx
Novartis Investigative Site, Riyadh
Novartis Investigative Site, Taipei
Novartis Investigative Site, Prague
Novartis Investigative Site, Berlin
Novartis Investigative Site, Rozzano
Novartis Investigative Site, Milan
Novartis Investigative Site, Milan
Novartis Investigative Site, Brescia
Novartis Investigative Site, Gaziantep
Novartis Investigative Site, Hanover
Novartis Investigative Site, Kuei-Shan Chiang
H Lee Moffitt Cancer Center and Research Institute HLM, Tampa
Novartis Investigative Site, Istanbul
Novartis Investigative Site, Verona
Vanderbilt University Medical Center Vanderbilt Med Ctr, Nashville
Novartis Investigative Site, Magdeburg
Novartis Investigative Site, Bologna
Novartis Investigative Site, Taichung
Novartis Investigative Site, Seville
Novartis Investigative Site, Modena
Novartis Investigative Site, Essen
Goshen Center for Cancer Care IU Health SC, Indianapolis
Novartis Investigative Site, Florence
Novartis Investigative Site, Chiang Mai
Novartis Investigative Site, Mainz
Novartis Investigative Site, Frankfurt
University of Chicago UC SC, Chicago
Novartis Investigative Site, Brno
Texas Oncology P A Texas Oncology Amarillo, Dallas
Texas Oncology P A TX Oncology Baylor, Dallas
University of Texas Southwestern Medical Center, Dallas
University of Texas MD Anderson Cancer Center UT MD Anderson Cancer Ctr, Houston
University of Colorado Cancer Centre SC, Aurora
Novartis Investigative Site, Napoli
Novartis Investigative Site, Napoli
Cedars Sinai Medical Center SC, Los Angeles
Scripps Clinic Regulatory, La Jolla
Novartis Investigative Site, Viagrande
Oregon Health and Science University OH&SU, Portland
Novartis Investigative Site, Bad Berka
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, Beijing
Novartis Investigative Site, El Achrafiyé
Novartis Investigative Site, Rostov-on-Don
University of California San Diego - Moores Cancer Center Regulatory, La Jolla
Dana Farber Cancer Institute SC, Boston
University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc, Madison
Novartis Investigative Site, Vienna
Novartis Investigative Site, Calgary
Novartis Investigative Site, Vancouver
Novartis Investigative Site, Halifax
Novartis Investigative Site, London
Novartis Investigative Site, Ottawa
Novartis Investigative Site, Toronto
Novartis Investigative Site, Montreal
Novartis Investigative Site, Bogotá
Novartis Investigative Site, Olomouc
Novartis Investigative Site, Athens
Novartis Investigative Site, Roma
Novartis Investigative Site, Roma
Novartis Investigative Site, Fukuoka
Novartis Investigative Site, Osaka
Novartis Investigative Site, Chuo Ku
Novartis Investigative Site, Beirut
Novartis Investigative Site, Amsterdam
Novartis Investigative Site, Gliwice
Novartis Investigative Site, Poznan
Novartis Investigative Site, Bratislava
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Seoul
Novartis Investigative Site, Barcelona
Novartis Investigative Site, L'Hospitalet de Llobregat
Novartis Investigative Site, Glasgow
Novartis Investigative Site, Cambridge
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Manchester
Novartis Investigative Site, Southampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY